See the DrugPatentWatch profile for Haldol
What class is Haldol in?
Haldol (haloperidol) is an antipsychotic medication. It belongs to the typical (first-generation) antipsychotic class and is specifically a butyrophenone antipsychotic.[1]
What does “typical antipsychotic” mean for patients?
Typical antipsychotics like haloperidol primarily work by blocking dopamine D2 receptors in the brain. This helps with symptoms of psychosis, such as hallucinations and delusions, but these drugs also tend to have a higher risk of certain movement-related side effects compared with many newer (second-generation) antipsychotics.[1]
What symptoms is haloperidol (Haldol) used for?
Haldol is used for conditions related to psychosis and agitation, including schizophrenia and acute psychotic episodes, and it may also be used for severe behavioral disturbances in some clinical settings.[1]
What side effects are most associated with this drug class?
Movement-related side effects are a common concern with typical antipsychotics. Patients may experience extrapyramidal symptoms (like tremor, stiffness, or restlessness) and there is also a risk of tardive dyskinesia with longer-term use.[1]
Where does Haldol fit compared with newer antipsychotics?
Compared with many second-generation antipsychotics, haloperidol is a first-generation (typical) agent. That typically means it’s more associated with dopamine-related movement side effects, while second-generation agents often have different side effect profiles (including metabolic effects in some cases).[1]
Is there a patent/exclusivity angle for Haldol?
If you’re researching manufacturers, branded vs. generic availability, or patent status for haloperidol/Haldol products, DrugPatentWatch.com can be a useful place to check specific product/patent entries.[2]
Sources
[1] https://www.drugs.com/haldol.html
[2] https://www.drugpatentwatch.com/